Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12006329 Protein degraders and uses thereof

Patent 12006329 was granted and assigned to Kymera Therapeutics on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Kymera Therapeutics

0

Current Assignee

Kymera Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Arthur F. Kluge0

Nello Mainolfi0

Nan Ji0

Date of Patent

June 11, 2024

0

Patent Application Number

178908470

Date Filed

August 18, 2022

0

Patent Citations

US Patent 7208157 Proteolysis targeting chimeric pharmaceutical

0

US Patent 6949537 PI-3 kinase inhibitor prodrugs

0

US Patent 7041298 Proteolysis targeting chimeric pharmaceutical

0

US Patent 7071189 Heterocyclic compound and antitumor agent containing the same as active ingredient

0

US Patent 7074620 Controlling protein levels in eucaryotic organisms

0

US Patent 7173015 Inhibition of Syk kinase expression

0

US Patent 8338439 2,4-disubstituted pyrimidines useful as kinase inhibitors

0

US Patent 8486941 Phenyl amino pyrimidine compounds and uses thereof

0

...

Patent Primary Examiner

Rebecca L Anderson

0

CPC Code

0

0

0

0

0

0

Patent abstract

The present invention provides compounds, compositions thereof, and methods of using the same for the targeted degradation of proteins, and the treatment of target protein-mediated disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12006329 Protein degraders and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool